STAT+: Alzheimer’s researchers try out an unfamiliar sensation: optimism
Scientific meetings about Alzheimer’s disease can be funereal affairs. But this year's Clinical Trials in Alzheimer’s Disease meeting felt markedly different.
News
STAT+: Pharmalittle: Biden administration to fine drugmakers for price hikes on 27 meds; Dems push pharmacy chains over access to abortion pill
The Biden administration will fine drugmakers that hiked prices faster than the inflation rate on 27 medicines administered in physician offices. […]
News
STAT+: Regeneron’s Eylea sales dip, as competition looms
The “meaningful Eylea miss could potentially foreshadow biosimilar challenges,” an analyst said about Regeneron’s drug. […]
News
STAT+: Kite to buy Tmunity Therapeutics, Carl June’s troubled CAR-T startup
Kite’s two recent deals represent notable investments in a type of CAR-T that some had thought may become obsolete. […]
